Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
“Like ADEK, HAD and OAK could interrupt androgen binding to the AR and suppress both dihydrotestosterone‐ and androstenediol‐induced transactivations of wild‐type and mutant ARs in prostate cancer cells.”